Old drug offers new hope against rare, deadly childhood disease​

Washington University School of Medicine in St. Louis is playing a leading role in one of the National Institutes of Health’s first clinical trials to improve treatments for rare and neglected diseases. In this case, the disease is Niemann-Pick Type C, a disorder that causes excess cholesterol to accumulate in the brain, liver and spleen. It affects about 500 children worldwide, leads to neurodegeneration, and usually causes death in the first two decades of life.

Ground broken for Shriners Hospital on Medical Campus​

A groundbreaking for a new, $50 million Shriners Hospitals for Children-St. Louis recently was held on the Washington University Medical Center campus. The planned hospital, at the corner of Clayton Road and Newstead Avenue, will replace the Shriners Hospital in Frontenac. Shown is a rendering of what the building will look like from Interstate 64/Highway 40.

Engineering breakthrough may answer host of medical questions

In an engineering breakthrough, a Washington University in St. Louis biomedical researcher has discovered a way to use light and color to measure oxygen in individual red blood cells in real time. The technology, developed by Lihong Wang, PhD, the Gene K. Beare Distinguished Professor of Biomedical Engineering, could eventually be used to determine how oxygen is delivered to normal and diseased tissues or how various disease therapies impact oxygen delivery throughout the body.
Older Stories